Reliq Health Technologies Inc V.RHT.H

A/R, part 2

[theinvestor22]

In terms of "trade and other receivables" (which is mostly SaaS, I would think), that balance sheet item went up by $978k from year end. Given that SaaS sales were $1,423k in fQ1, that would seem to indicate that Reliq is continuing to chip away at collections.  My recollection is that they collected something material in each of the previous 3 quarters as well.  So, the general argument that "Reliq can't collect" isn't valid.  The argument that Reliq needs to focus strongly on collections, is probably a more appropriate one.